Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Drug-specific variables that may affect half-life Drug formulation (ie, modified or controlled release preparations extend half-life) How the drug behaves in the body (ie, zero-order, first-order, or multi-compartmental pharmacokinetics) How the drug is administered (half-life may be different with IV administration, compared to intranasal or oral administration) How the drug is cleared from the body (eg, kidneys, liver, lungs) If the drug accumulates in fat or other types of tissue If the drug binds to proteins or not Presence of metabolites or other drugs that may interact Properties of the drug, including molecule size, charge, and pKa The volume of distribution of a drug Other variables, such as if the drug is actively transported, is self-induced, or has saturation pharmacokinetics
The peptide remains viable for 28 days maximum when refrigerated at 28C
10.1158/0008-5472.Can-03-3909 Cancer Res
Effects fade when you stop, and chasing permanence with continued high-dose injections is where the safety risk climbs
Appendicite aigu
US$ 24.30
US$ 29.52
US$ 22.90
US$ 21.77
